Dedicated locality research platform
Enter your email address and you will receive
a link to reset your password
The JP Taparia family, founders of the pharmaceutical company Famy Care, has reportedly purchased India's most expensive triplex apartment in Malabar Hill, south Mumbai, for over Rs 369 crore. The apartment is situated on the 26th, 27th, and 28th floors of the Lodha Malabar, a super-luxury residential tower on Walkeshwar Road, overlooking both the Arabian Sea and the Hanging Gardens. The transaction sets a new record for the most expensive apartment deal in India, surpassing the recent sale of a penthouse in the same tower to Bajaj Auto chairman Niraj Bajaj for over Rs 252.50 crore.
The Taparias have reportedly paid stamp duty worth Rs 19.07 crore for the registration of the deal, which was finalized last Wednesday evening. The triplex apartment spans a massive 27,160 sqft, and the deal values it at nearly Rs 1.36 lakh per sq ft, making it one of the country's most expensive residential transactions on a per sqft basis.
The deal was completed with the Lodha Group's listed entity, Macrotech Developers. The under-construction luxury tower, spread over a total of 1.08 acres, is scheduled to be completed by June 2026, according to regulatory filings.
The Taparia family's healthcare business, Famy Life Sciences, was acquired by Viatris Inc, formerly Mylan Labs, in November 2022, for around $300 million or over Rs 2,460 crore. The family retained the non-ophthalmic business, which is expected to continue growing. The Taparia Group's business interests also include private equity from Anantha Capital, multiple consumer, and pharmaceutical businesses, including Springwel and Guardian Pharmacy.
The recent announcement made in the Union Budget 2023-24 has reportedly led to an increase in the sale of luxury properties in India. The budget announced that the deduction from capital gains on investment in residential property would be limited to Rs 10 crore from April 1st, 2023. This change is expected to impact the demand for high-end luxury homes, as investors may now consider investing in properties that are priced below the new limit.
The move is aimed at curbing the practice of wealthy investors using real estate as a tax-saving tool. It is expected to impact investors who have invested in multiple high-value properties with the intent of claiming large capital gains deductions. The impact of the budget announcement has been seen in recent transactions in Mumbai's luxury real estate market, with multiple high-value property deals being reported in quick succession. The sale of the luxury triplex apartment in Malabar Hill for Rs 369 crore is just one example of the trend.
Last month, Welspun Group chairman BK Goenka purchased a penthouse in Mumbai's affluent Worli locality for Rs 240 crore, making it the most expensive residential transaction at the time. In the same project, Oberoi Realty paid Rs 230.55 crore for another luxury penthouse. Last week, Madhav Arun Goel, director of leading synthetic rope manufacturer Tufropes, also purchased a sea-view luxury apartment for Rs 121 crore in the Lodha Group's Malabar Hill project.
Malabar Hill and Walkeshwar Road are among the most sought-after addresses in India, known for their proximity to business hubs and traditional luxury areas. The micro-market houses many high-profile names, including industrialists, corporate leaders, wealthy individuals, and C-Suite professionals.
Propscience is India’s dedicated property news portal. We cover the latest events, news, trends, deals, new launches and more.
All our services and tools are completely free of cost and available 24X7!
We use cookies to give you the best possible service while using our website, please click accept and carry on browsing if you're happy with this. For more information see our Privacy Policy.
Okay, Got it!This disclaimer ("Disclaimer") is applicable to the entire Site. Upon entering the Site it is recommended that you immediately read the Terms and Conditions and Privacy Policy listed therein. Your continued usage of this Site will indicate your unconditional acceptance of the said Terms and Conditions and Privacy Policy. You hereby agree that Propscience reserves the right to modify at any time, the Terms and Conditions and Privacy Policy governing this Site without prior notification. Your usage of the Site implies that you will be bound by any such modification. You agree and acknowledge that it is your responsibility to periodically visit the Site and stay updated with the Terms and Conditions and Privacy Policy of the Website.
The information contained in this Site has been provided by Propscience for information purposes only. This information does not constitute legal, professional or commercial advice. Communication, content and material within the Site may include photographs and conceptual representations of projects under development. All computer-generated images shown on the Site are only indicative of actual designs and are sourced from third party sites.
The information on this Site may contain certain technical inaccuracies and typographical errors. Any errors or omissions brought to the attention of Propscience will be corrected as soon as possible. The content of this Site is being constantly modified to meet the terms, stipulations and recommendations of the Real Estate Regulation Act, 2016 ("RERA") and rules made thereunder and may vary from the content available as of date. All content may be updated from time to time and may at times be out of date. Propscience accepts no responsibility for keeping the information in this website up to date or any liability whatsoever for any failure to do so.
While every care has been taken to ensure that the content is useful, reliable and accurate, all content and information on the Site is provided on an "as is" and "as available" basis. Propscience does not accept any responsibility or liability with regard to the content, accuracy, legality and reliability of the information provided herein, or, for any loss or damage caused arising directly or indirectly in connection with reliance on the use of such information. No information given under this Site creates a warranty or expands the scope of any warranty that cannot be disclaimed under applicable law.
This Site provides links to other websites owned by third parties. Any reference or mention to third party websites, projects or services is for purely informational purposes only. This information does not constitute either an endorsement or a recommendation. Propscience accepts no responsibility for the content, reliability and information provided on these third-party websites. Propscience will not be held liable for any personal information of data collected by these third parties or for any virus or destructive properties that may be present on these third-party sites.
Your use of the Site is solely at your own risk. You agree and acknowledge that you are solely responsible for any action you take based upon this content and that Propscience is not liable for the same. All details regarding a project/property provided on this Site are updated on the basis of information available from the respective developers/owners/promoters. All such information will not be construed as an advertisement. To find out more about a project / development, please register/contact us to visit the site you are interested in. All decisions taken by you in this regard will be taken independently and Propscience will not be liable for any such loss in connection with the same. This Site is for guidance only. Your use of this Site - including any suggestions set out in the Site and or any use of the resources available on this Site, do not create any professional - client relationship between you and Propscience. Propscience cannot accept you as a client until certain formalities and requirements are met.
We use cookies to give you the best possible service while using our website, please accept it and continue browsing if you're happy with this. For more information see our Privacy Policy